FdaApplication
NDA 022301
Identifiers
- fda_app_no: NDA022301
Properties
| Property | Value |
|---|---|
| applicant_name | SALIX PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2008-10-31 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APRISO | MESALAMINE | 375MG | CAPSULE, EXTENDED RELEASE;ORAL |
1 product